Cue Biopharma (CUE) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Cue Biopharma (CUE) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Cue Biopharma

· CUE

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

185.315 M

+1.41%

General

Market Cap: $185.32M
Enterprise Value: $179.35M
Shares Outstanding: 4,050,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 99.69%
Operating Margin: -261.97%
Net Profit Margin: -435.83%
FCF Margin: -133.23%
ROA: -534.43%
ROE: -1032.19%
ROIC: -887.33%
Current Ratio: 1.25
Debt-to-Equity: 3.81
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -0.01
P/S: 4.99
P/FCF: —
P/B: 81.36
EV/EBITDA: -1.87

Growth

Rev 1Y: —
Rev 1Y Fwd Est: -43.13%
Rev 3Y (CAGR): 180.46%
Rev 5Y (CAGR): 54.16%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $37.65M
Gross Margin: 99.69%
Operating Expenses: $136.22M
Operating Income: -$98.64M
Net Profit: -$164.11M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $17.39M
Working Capital: $5.41M
Total Assets: $30.71M
Net Debt: -$8.59M
Total Liabilities: $28.4M
Total Equity: $2.31M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$50.05M
Cash Flow from Investing: $131K
Cash Flow from Financing: $39.82M
Free Cash Flow: -$50.17M
Capital Expenditures: $121K